News
The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.
Moderna disclosed that a study of 56,000 volunteers older than 50 found its new mRNA flu vaccine was more effective than an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results